CD8A and gastric cancer: More recently, a novel co-culture approach was developed to predict the efficacy of precision medicine to achieve a better prognosis for gastric cancer patients, using tumor antigens to stimulate antigen-presenting dendritic cells (DCs), followed by co-culture with CD8+ T cells to promote cytolysis and proliferation of these T cells before co-culture with patient-derived gastric cancer organoids (51).